|
  
OVERVIEW
CovaMed was formed in December of 2002 and is working on developing new surgical adhesives and hemostats. The company is headquartered in Ann Arbor, Michigan and is privately owned and funded.
MISSION
Covalent Medical's mission is to be a leader in preventing the leakage of blood, gas or fluid through the design, development, manufacturing and commercialization of innovative biomaterials, adhesive technologies, and application delivery systems. Our products are designed to improve patient outcome primarily in operating theatres and trauma centers. CovaMed will strive to maintain the highest possible customer satisfaction by ensuring that we are responsive to customers' needs. We intend to make sufficient profit to generate a fair return for our investors and to finance continued growth and development in quality products. CovaMed will maintain an ethical, friendly, fair, and creative work environment that respects diversity, new ideas, and hard work.
THE MARKET
CovaMed is participating in a worldwide market that is estimated to be in excess of $1.4 billion and growing to $2.8 billion by 2010. Within this market, CovaMed's products are focused on the cardiovascular and trauma segments, but have shown potential applications in other areas. The current products, CovaBOND and CovaSTAT are designed to address severely bleeding surfaces for which there is currently limited treatment and also to provide a replacement method for suturing and stapling in minimally invasive surgical procedures..
PARTNERS
CovaMed is continually looking for partnering opportunities. For more information, please contact us at (734) 429-2451 or send an e-mail to partner@covamed.com
|
